Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in developing kinase inhibitors for targeted cancer therapies. Its structure enables selective binding to enzyme active sites, making it valuable in drug discovery programs focused on oncology and inflammatory diseases. The compound's functional groups allow for further chemical modifications, facilitating the development of novel derivatives with improved potency and selectivity. It is also employed in research settings to explore structure-activity relationships in central nervous system drug candidates due to its ability to cross the blood-brain barrier.